November 29, 2009 — A second-generation CR-based Full Field Digital Mammography (FFDM) marks the evolution of the only FDA-approved CR-based mammography solution available in the United States, according to the company.

The new system, called Aspire ClearView, delivers the same exceptional image quality as before with enhanced features and an upgraded technologist workstation.

The system’s enhancements include a sleeker design, lighter weight and a wider viewing angle on the LCD offering additional flexibility for room placement. ClearView will continue to be offered in a single slot and four-slot design. ClearView remains the only approved FFDM that can perform general x-ray imaging.

The latest evolution of the Aspire ClearView workstation, the AWS-c, will be the first color workstation available for technologists. This new workstation offers technologists an improved graphic user interface (GUI) with a full color, high brightness, 2 mega pixel LCD monitor in portrait format for quick recognition of important patient and exposure information.

A user-friendly technologist GUI will be available with both the AWS-c and the AWS-d, the workstation that will be paired with Fujifilm’s new Aspire HD2, DR-based FFDM system. This will provide consistency across product lines for a streamlined workflow and greater efficiency for the user of either of Fujifilm’s FFDM offerings. Also available for the first time is an optional high resolution, 3 mega pixel or 5 mega pixel, greyscale companion monitor for quick confirmation of the acquired image.

The new Aspire ClearView readers are expected to be available in the first half of 2010. The AWS-c will be commercially available upon receipt of pending FDA approval.

For more information: www.fujimed.com.


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
Subscribe Now